Total Payments
$3,543
2024 Payments
$153.31
Companies
17
Transactions
45
Medicare Patients
616
Medicare Billing
$110,513
Payment Breakdown by Category
Consulting$2,000 (56.4%)
Food & Beverage$1,306 (36.9%)
Education$236.79 (6.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,000 | 2 | 56.4% |
| Food and Beverage | $1,306 | 39 | 36.9% |
| Education | $236.79 | 4 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $2,000 | 2 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $427.17 | 14 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $212.13 | 8 | $0 (2022) |
| Fisher & Paykel Healthcare Inc | $185.38 | 1 | $0 (2021) |
| Abbott Laboratories | $178.09 | 1 | $0 (2023) |
| Kyowa Kirin, Inc. | $124.11 | 1 | $0 (2021) |
| LivaNova USA, Inc. | $80.57 | 2 | $0 (2023) |
| ABBVIE INC. | $55.96 | 2 | $0 (2024) |
| EMD Serono, Inc. | $51.83 | 3 | $0 (2019) |
| Boston Scientific Corporation | $43.14 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.31 | 6 | Boston Scientific Corporation ($43.14) |
| 2023 | $443.85 | 8 | Abbott Laboratories ($178.09) |
| 2022 | $114.63 | 5 | Neurocrine Biosciences, Inc. ($51.05) |
| 2021 | $548.34 | 12 | Fisher & Paykel Healthcare Inc ($185.38) |
| 2020 | $2,220 | 10 | Daiichi Sankyo Inc. ($2,000) |
| 2019 | $51.83 | 3 | EMD Serono, Inc. ($51.83) |
| 2017 | $10.88 | 1 | US WorldMeds, LLC ($10.88) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $43.14 | General |
| Category: Vercise_NMD | ||||||
| 09/12/2024 | Azurity Pharmaceuticals, Inc. | ZONISADE (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 06/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Central Nervous System | ||||||
| 02/22/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Neurology | ||||||
| 02/12/2024 | Azurity Pharmaceuticals, Inc. | ZONISADE (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 01/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Central Nervous System | ||||||
| 11/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $44.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $35.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/08/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $178.09 | General |
| Category: Neuromodulation | ||||||
| 08/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Central Nervous System | ||||||
| 06/16/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Central Nervous System | ||||||
| 06/12/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.45 | General |
| 12/16/2022 | Avion Pharmaceuticals | Dhivy (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Parkinson's disease | ||||||
| 09/16/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Neuropsychiatry | ||||||
| 06/03/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Central Nervous System | ||||||
| 04/08/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Central Nervous System | ||||||
| 02/19/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Neuropsychiatry | ||||||
| 12/21/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 12/11/2021 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug), INGREZZA | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: NEUROLOGY | ||||||
| 11/17/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 11/12/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Central Nervous System | ||||||
| 11/08/2021 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug), INGREZZA | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 166 | 295 | $229,651 | $34,725 |
| 2022 | 5 | 165 | 275 | $194,209 | $34,334 |
| 2021 | 5 | 164 | 223 | $165,550 | $28,270 |
| 2020 | 4 | 121 | 177 | $85,585 | $13,185 |
Total Patients
616
Total Services
970
Medicare Billing
$110,513
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 78 | 172 | $134,450 | $20,949 | 15.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 42 | $27,040 | $4,642 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $25,090 | $3,802 | 15.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 26 | $29,896 | $3,164 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 15 | $7,575 | $1,308 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 14 | $5,600 | $859.18 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 87 | 169 | $114,920 | $21,665 | 18.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 33 | 33 | $31,845 | $5,487 | 17.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 43 | $24,725 | $3,957 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 18 | $9,090 | $1,672 | 18.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 12 | $13,629 | $1,553 | 11.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 69 | 120 | $79,920 | $16,205 | 20.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 36 | 36 | $41,395 | $4,512 | 10.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $23,575 | $4,444 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 23 | 27 | $12,975 | $2,095 | 16.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 15 | $7,685 | $1,014 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 62 | 95 | $42,275 | $5,901 | 14.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 22 | 45 | $16,650 | $3,251 | 19.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 25 | 25 | $17,000 | $2,855 | 16.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 12 | $9,660 | $1,178 | 12.2% |
About Dr. David Kaufman, MD
Dr. David Kaufman, MD is a Neurology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124103817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kaufman, MD has received a total of $3,543 in payments from pharmaceutical and medical device companies, with $153.31 received in 2024. These payments were reported across 45 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($2,000).
As a Medicare-enrolled provider, Kaufman has provided services to 616 Medicare beneficiaries, totaling 970 services with total Medicare billing of $110,513. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Bronx, NY
- Active Since 10/25/2006
- Last Updated 01/31/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1124103817
Products in Payments
- Savaysa (Drug) $2,000
- PT101US/Airvo 2 (Device) $185.38
- ETERNA (Device) $178.09
- ONGENTYS (Drug) $161.08
- AUSTEDO (Drug) $152.64
- NOURIANZ (Drug) $124.11
- BOTOX (Biological) $84.69
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $80.57
- Austedo XR (Drug) $64.08
- Mavenclad (Biological) $51.83
- Vercise (Device) $43.14
- ZONISADE (Drug) $38.32
- Phexxi (Drug) $37.24
- INGREZZA (Drug) $31.85
- Fintepla (Drug) $25.55
- VUMERITY (Drug) $22.35
- Dhivy (Drug) $21.65
- Ongentys (Drug) $19.20
- Xadago (Drug) $10.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bronx
Richard Lipton, Md, MD
Neurology — Payments: $982,914
Neurology $982,914
Michael Thorpy, Md, MD
Neurology — Payments: $451,587
Neurology $451,587
Rene Elkin, Md, MD
Neurology — Payments: $343,327
Neurology $343,327
Jelena Pavlovic, M.d, M.D
Neurology — Payments: $130,235
Neurology $130,235
Dr. Sandeep Gulati, D.o, D.O
Neurology — Payments: $124,853
Neurology $124,853
Dr. Lauren Gluck, Md, MD
Neurology — Payments: $53,848
Neurology $53,848